HD Insights
  • Home
  • About HD Insights
  • Contact
  • Back to HSG
HD Insights
  • Home
  • About HD Insights
  • Contact
  • Back to HSG
huntington's disease research paper

A Letter From Our Editor

Posted by Steve Bucciarelli - May 13, 2017
Read More
huntington disease latest news

FDA approves deutetrabenazine (AUSTEDO™) to treat chorea

Posted by Steve Bucciarelli - April 22, 2017
On April 3, 2017, the FDA approved a new drug, deutetrabenazine, to treat HD-associated chorea.…
Read More

Research Round-Up

Posted by Steve Bucciarelli - February 22, 2017
Read More
neurological disorders research

Meet The Scientist

Posted by Steve Bucciarelli - February 22, 2017
Read More

Game-changing gene-silencing therapies for HD

Posted by Steve Bucciarelli - February 22, 2017
Read More
Highlights of CHDI

Highlights of CHDI

Posted by Steve Bucciarelli - February 22, 2017
Read More

Highlights from the Journal of HD

Posted by Steve Bucciarelli - May 30, 2017
Read More
huntington's disease gene silencing

Gene-Targeting Therapies for HD

Posted by Steve Bucciarelli - April 22, 2017
Read More

HD Research Around the World: Brazil

Posted by Steve Bucciarelli - February 5, 2017
Dramatically maintain high-payoff processes rather than mission-critical mindshare. Conveniently revolutionize client-based niches before market-driven architectures.…
Read More

About HD Insights

Our mission is to promote, disseminate, and facilitate research on Huntington’s disease. To fulfill this mission, we are guided by an outstanding editorial board that includes representatives from three continents, academia, industry, and the HD community.

More Information

Past Issues

  • Vol. 26
  • Vol. 25
  • Vol. 24
  • Vol. 23
  • Vol 22
  • Vol 21
  • Vol 20
  • Vol 19
  • Vol. 18
  • Vol. 17

Navigation

  • Home
  • Editorial Board
  • Contact Us

Recent Posts

  • From the Editor: A BOOST OF ENCOURAGEMENT
  • Featured Story: Safeguarding the Integrity of Clinical Research
  • Featured Story: A New Staging System for More Targeted Research
  • Featured Story: Multiple New Approaches in HD Therapy
  • In Brief: Huntington Study Group Launches New Online Study Platform
  • In Brief: A New Champion for HD Youth

Contact HSG

Huntington Study Group
95 Allen’s Creek Road, Building 1, Suite 132
Rochester, NY 14618, USA

Toll Free (North America):
800-487-7671

Fax: 585-672-9912

Email: info@hsglimited.org

SMARTSite by Site Hub 2018

  • Home
  • Editorial Board
  • Contact Us